Current diagnosis and management of cardiac myxomas

References

• Tamin SS, Khan SK, Maleszewski JJ, et al. Papillary fibroelastoma: an unexpectedly common cardiac mass. Presented at Rapid Fire Oral Abstracts: Valvular Heart Disease. American Society of Echocardiography 23rd Annual Scientific Sessions. 30 June 2012–3 July 2012. Maryland, USA
   Google Scholar
• Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993;117:1027-31
   PubMed Web of Science ®Google Scholar
• Reynen K. Frequency of primary tumors of the heart. Am J Cardiol 1996;77:107
   PubMed Web of Science ®Google Scholar
• Sutsch G, Jenni R, von Segesser L, Schneider J. [Heart tumors: incidence, distribution, diagnosis. Exemplified by 20,305 echocardiographies]. Schweiz Med Wochenschr 1991;121:621-9
   PubMedGoogle Scholar
• King G. Observations on the Inquest Held on the Late General Dick, and on the Cause of Death. Prov Med Surg J 1845;9:650-1
   PubMedGoogle Scholar
• Chitwood WRJr. Clarence Crafoord and the first successful resection of a cardiac myxoma. Ann Thorac Surg 1992;54:997-8
   PubMedGoogle Scholar
• Reynen K. Cardiac myxomas. N Engl J Med 1995;333:1610-17
   PubMed Web of Science ®Google Scholar
• Centofanti P, Di Rosa E, Deorsola L, et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg 1999;68:1236-41
   PubMed Web of Science ®Google Scholar
• Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine 2001;80:159-72
   PubMed Web of Science ®Google Scholar
• Jain D, Maleszewski JJ, Halushka MK. Benign cardiac tumors and tumorlike conditions. Ann Diagn Pathol 2010;14:215-30
   PubMed Web of Science ®Google Scholar
• Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 1985;64:270-83
   PubMed Web of Science ®Google Scholar
• Stergiopoulos SG, Stratakis CA. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!. FEBS Lett 2003;546:59-64
   PubMed Web of Science ®Google Scholar
• Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86:4041-6
   PubMed Web of Science ®Google Scholar
• Boikos SA, Stratakis CA. Carney complex: pathology and molecular genetics. Neuroendocrinology 2006;83:189-99
   PubMed Web of Science ®Google Scholar
• McCarthy PM, Piehler JM, Schaff HV, et al. The significance of multiple, recurrent, and ‘complex’ cardiac myxomas. J Thorac Cardiovasc Surg 1986;91:389-96
   PubMedGoogle Scholar
• Vidaillet HJJr, Seward JB, Fyke FE3rd, et al. ‘Syndrome myxoma’: a subset of patients with cardiac myxoma associated with pigmented skin lesions and peripheral and endocrine neoplasms. Br Heart J 1987;57:247-55
   PubMedGoogle Scholar
• Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92
   PubMed Web of Science ®Google Scholar
• Maleszewski JJ, Larsen BT, Kip NS, et al. PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors. Am J Surg Pathol 2014;38:1079-87
   PubMed Web of Science ®Google Scholar
• Pucci A, Gagliardotto P, Zanini C, et al. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000;140:134-8
   PubMed Web of Science ®Google Scholar
• Tazelaar HD, Locke TJ, McGregor CG. Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc 1992;67:957-65
   PubMed Web of Science ®Google Scholar
• Svec A, Rangaiah M, Giles M, et al. EBV+ diffuse large B-cell lymphoma arising within atrial myxoma. An example of a distinct primary cardiac EBV+ DLBCL of immunocompetent patients. Pathol Res Pract 2012;208:172-6
   PubMed Web of Science ®Google Scholar
• Bartoloni G, Pucci A, Giorlandino A, et al. Incidental Epstein-Barr virus associated atypical lymphoid proliferation arising in a left atrial myxoma: a case of long survival without any postsurgical treatment and review of the literature. Cardiovasc Pathol 2013;22:e5-10
   Google Scholar
• Aguilar C, Beltran B, Quinones P, et al. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 2015;24:60-4
   PubMed Web of Science ®Google Scholar
• Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993;100:671-80
   PubMed Web of Science ®Google Scholar
• Seino Y, Ikeda U, Shimada K. Increased expression of interleukin 6 mRNA in cardiac myxomas. Br Heart J 1993;69:565-7
   PubMedGoogle Scholar
• Kanda T, Umeyama S, Sasaki A, et al. Interleukin-6 and cardiac myxoma. Am J Cardiol 1994;74:965-7
   PubMedGoogle Scholar
• Sakamoto H, Sakamaki T, Sumino H, et al. Production of endothelin-1 and big endothelin-1 by human cardiac myxoma cells–implications of the origin of myxomas. Circ J 2004;68:1230-2
   PubMedGoogle Scholar
• Yokomuro H, Yoshihara K, Watanabe Y, et al. The variations in the immunologic features and interleukin-6 levels for the surgical treatment of cardiac myxomas. Surg Today 2007;37:750-3
   PubMedGoogle Scholar
• Mendoza CE, Rosado MF, Bernal L. The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J 2001;28:3-7
   PubMed Web of Science ®Google Scholar
• Lee VH, Connolly HM, Brown RDJr. Central nervous system manifestations of cardiac myxoma. Arch Neurol 2007;64:1115-20
   PubMedGoogle Scholar
• Keeling IM, Oberwalder P, Anelli-Monti M, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002;22:971-7
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Khattar RS, Gujral DM, Senior R. Cardiac tumors: the role of cardiovascular imaging. Expert Rev Cardiovasc Ther 2014;12:37-43
   PubMedGoogle Scholar
• Schattenberg TT. Echocardiographic diagnosis of left atrial myxoma. Mayo Clin Proc 1968;43:620-7
   PubMedGoogle Scholar
• Ha JW, Kang WC, Chung N, et al. Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism. Am J Cardiol 1999;83:1579-82; A1578
   PubMedGoogle Scholar
• Peters PJ, Reinhardt S. The echocardiographic evaluation of intracardiac masses: a review. J Am Soc Echocardiogr 2006;19:230-40
   PubMed Web of Science ®Google Scholar
• Kirkpatrick JN, Wong T, Bednarz JE, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol 2004;43:1412-19
   PubMedGoogle Scholar
• Reeder GS, Khandheria BK, Seward JB, Tajik AJ. Transesophageal echocardiography and cardiac masses. Mayo Clin Proc 1991;66:1101-9
   PubMed Web of Science ®Google Scholar
• Mehmood F, Nanda NC, Vengala S, et al. Live three-dimensional transthoracic echocardiographic assessment of left atrial tumors. Echocardiography 2005;22:137-43
   PubMedGoogle Scholar
• Plana JC. Added value of real-time three-dimensional echocardiography in assessing cardiac masses. Curr Cardiol Rep 2009;11:205-9
   PubMedGoogle Scholar
• Zaragoza-Macias E, Chen MA, Gill EA. Real time three-dimensional echocardiography evaluation of intracardiac masses. Echocardiography 2012;29:207-19
   PubMed Web of Science ®Google Scholar
• Araoz PA, Mulvagh SL, Tazelaar HD, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 2000;20:1303-19
   PubMed Web of Science ®Google Scholar
• Fussen S, De Boeck BW, Zellweger MJ, et al. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. Eur Heart J 2011;32:1551-60
   PubMed Web of Science ®Google Scholar
• Motwani M, Kidambi A, Herzog BA, et al. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology 2013;268:26-43
   PubMed Web of Science ®Google Scholar
• Garatti A, Nano G, Canziani A, et al. Surgical excision of cardiac myxomas: twenty years experience at a single institution. Ann Thorac Surg 2012;93:825-31
   PubMedGoogle Scholar
• Samanidis G, Perreas K, Kalogris P, et al. Surgical treatment of primary intracardiac myxoma: 19 years of experience. Interact Cardiovasc Thorac Surg 2011;13:597-600
   PubMedGoogle Scholar
• Patil NP, Dutta N, Satyarthy S, et al. Cardiac myxomas: experience over one decade. J Card Surg 2011;26:355-9
   PubMedGoogle Scholar
• Ko PJ, Chang CH, Lin PJ, et al. Video-assisted minimal access in excision of left atrial myxoma. Ann Thorac Surg 1998;66:1301-5
   PubMedGoogle Scholar
• Rathore KS, Hussenbocus S, Stuklis R, Edwards J. Novel strategies for recurrent cardiac myxoma. Ann Thorac Surg 2008;85:2125-6
   PubMedGoogle Scholar
• Yu S, Xu X, Zhao B, et al. Totally thoracoscopic surgical resection of cardiac myxoma in 12 patients. Ann Thorac Surg 2010;90:674-6
   PubMedGoogle Scholar
• Konecny T, Reeder G, Noseworthy PA, et al. Percutaneous ablation and retrieval of a right atrial myxoma. Heart Lung Circ 2014;23:e244-7
   Google Scholar
• Gammie JS, Abrishamchian AR, Griffith BP. Cardiac autotransplantation and radical bi-atrial resection for recurrent atrial myxoma. Ann Thorac Surg 2007;83:1545-7
   PubMedGoogle Scholar
• Aguilar C, Beltran B, Quinones P, et al. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 2015;24:60-4
   PubMed Web of Science ®Google Scholar
• Gruver AM, Huba MA, Dogan A, Hsi ED. Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas. Am J Surg Pathol 2012;36:1527-37
   PubMedGoogle Scholar